Sumitomo Mitsui Trust Holdings, Inc. Ionis Pharmaceuticals Inc Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $134 Billion
- Q2 2024
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 199,231 shares of IONS stock, worth $8.52 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
199,231
Previous 220,261
9.55%
Holding current value
$8.52 Million
Previous $9.55 Million
0.56%
% of portfolio
0.01%
Previous 0.01%
Shares
22 transactions
Others Institutions Holding IONS
# of Institutions
394Shares Held
125MCall Options Held
2.25MPut Options Held
510K-
Vanguard Group Inc Valley Forge, PA13.8MShares$592 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD12.6MShares$540 Million0.38% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$441 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.26MShares$353 Million6.59% of portfolio
-
Wellington Management Group LLP Boston, MA6.57MShares$281 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $6.07B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...